4
Changes in Ownership
Faeth Therapeutics, Inc. Filed Acc 0002137706-26-000003
Director acquired 44,763 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hahn Stephen M. Director | 2026-06-15 | Conversion | +44,763 | 44,763 | D | ||
| Derivatives | |||||||
| Hahn Stephen M. Director | 2026-06-12 | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | D | ||
| Hahn Stephen M. Director | 2026-06-15 | Conversion · Series B Preferred Stock | −44.76 | 0 | D | ||
Loading xslF345X06/form4-06162026_080601.xml…